Cefotaxime is more effective than is ampicillin‐tobramycin in cirrhotics with severe infections

Hepatology

Volumn 5, Issue 3, 1985, Pages 457-462

  Felisart, Josefina ^a   Rimola, Antoni ^a   Arroyo, Vicente ^a   Perez‐Ayuso, Rosa M ^a   Quintero, Enrique ^a   Gines, Pere ^a   Rodes, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFOTAXIME; PENICILLIN G; TOBRAMYCIN;

BACTERIAL INFECTION; CLINICAL ARTICLE; DRUG COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG THERAPY; ETIOLOGY; HUMAN; INFECTION; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; METHODOLOGY; NEPHROTOXICITY; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; THERAPY;

ADULT; AMPICILLIN; BACTERIAL INFECTIONS; BETA 2-MICROGLOBULIN; CEFOTAXIME; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TOBRAMYCIN;

EID: 0021868184     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840050319     Document Type: Article

References (40)

1. Spontaneous bacterial peritonitis in cirrhosis: enedmic or epidemic?
2. Spontaneous bacterial peritonitis
3. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis
4. Portal hypertension and its complications. Bleeding esophageal varices, ascites and spontaneous bacterial peritonitis
5. Septicémie porto‐cave. Cirrhose du foie et septicémie à colibacile
6. Infecciones bacterianas agudas en la cirrosis hepática
7. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients
8. 2‐microglobulin to discriminate functional renal failure from acute tubular damage
9. Antibiotic combination‐associated nephrotoxocity in granulocytopenic patients with cancer
10. Empiric therapy for cancer patients: comparative study of ticarcillin‐tobramycin, ticarcillin‐cephalothin and cephalothin‐tobramycin
11. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside
12. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use
13. Antibacterial activity of cefotaxime and other newer cephalosporins ( in vitro and in vivo)
14. Antibacterial activity of cefotaxime
15. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases
16. Cefotaxime therapy of serious bacterial infection in adults
17. Cefotaxime in serious infections. A clinical and pharmacokinetic study
18. Gentamicin therapy in renal failure: a nomogram for dosage
19. 2‐microglobulin
20. Aminoglycoside neprho‐toxicity in critically ill surgical patients
21. Cefotaxime: pharmacokinetics and in vitro antibacterial activity of serum and urine in normal human volunteers
22. Concentrations of cefotaxime in human tissues and fluids. A review of published data
23. Cefotaxime concentrations in ascites
24. Sensitivity testing and synergy
25. Tobramycin: an overview
26. The nephrotoxicity of antimicrobial agents
27. Experience in monitoring gentamicin therapy during treatment of serious gram‐negative sepsis
28. Laboratory and clinical evaluation of tobramycin, a new aminoglycoside antibiotic
29. Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serum
30. The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function
31. Gentamicin pharmacokinetics in 1640 patients: method for control of serum concentrations
32. Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis
33. Serum complement in chronic liver disease
34. In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis
35. Clinical evaluation of tobramycin in respiratory and systemic infections in immunodepressed and normal patients
36. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients
37. Clinical comparison of cefotaxime versus the combination of gentamicin plus clindamycin in the treatment of peritonitis and similar polymicrobial soft tissue surgical sepsis
38. Cefotaxime in urinary tract infection: comparative clinical studies with gentamicin and with cefoxitin
39. A prospective randomized controlled trial of cefoxitin versus clindamycin‐aminoglycoside in mixed anaerobic‐aerobic infections
40. A comparative study of cefamandole versus gentamicin plus clindamycin in the treatment of documented or suspected bacterial peritonitis